134 related articles for article (PubMed ID: 34924471)
1. [Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia].
Ide T; Iida K; Katsuya H; Ito H; Aishima S; Hara H
Rinsho Shinkeigaku; 2022 Jan; 62(1):33-38. PubMed ID: 34924471
[TBL] [Abstract][Full Text] [Related]
2. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M
Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226
[TBL] [Abstract][Full Text] [Related]
3. Graft-Versus-Host-Disease of the Central Nervous System and Lung in a Patient With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Li Z; Wen X; Geng Y; Wu T
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1088-e1092. PubMed ID: 33480650
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience.
Fukushima T; Taguchi J; Moriuchi Y; Yoshida S; Itonaga H; Ando K; Sawayama Y; Imaizumi Y; Imanishi D; Hata T; Miyazaki Y
Int J Hematol; 2011 Oct; 94(4):390-394. PubMed ID: 21960057
[TBL] [Abstract][Full Text] [Related]
5. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
Min GJ; Park S; Park SS; Yoon JH; Lee SE; Cho BS; Eom KS; Lee S; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Kim YJ
Int J Hematol; 2019 Nov; 110(5):635-639. PubMed ID: 31309419
[TBL] [Abstract][Full Text] [Related]
6. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.
Kanda J; Hishizawa M; Utsunomiya A; Taniguchi S; Eto T; Moriuchi Y; Tanosaki R; Kawano F; Miyazaki Y; Masuda M; Nagafuji K; Hara M; Takanashi M; Kai S; Atsuta Y; Suzuki R; Kawase T; Matsuo K; Nagamura-Inoue T; Kato S; Sakamaki H; Morishima Y; Okamura J; Ichinohe T; Uchiyama T
Blood; 2012 Mar; 119(9):2141-8. PubMed ID: 22234682
[TBL] [Abstract][Full Text] [Related]
7. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
[TBL] [Abstract][Full Text] [Related]
8. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Kaito Y; Yui S; Inai K; Onai D; Kinoshita R; Yamanaka S; Okamoto M; Wada R; Ohashi R; Inokuchi K; Yamaguchi H
Intern Med; 2021; 60(20):3299-3304. PubMed ID: 34657908
[TBL] [Abstract][Full Text] [Related]
10. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
Front Immunol; 2020; 11():668. PubMed ID: 32431694
[TBL] [Abstract][Full Text] [Related]
11. Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Takahashi K; Katayama T; Ichikawa T; Matsuoka S; Kakinoki Y; Yoneda M; Kimura A; Koyama S; Yahara O
Intern Med; 2023 Mar; 62(5):779-786. PubMed ID: 35945030
[TBL] [Abstract][Full Text] [Related]
12. The black swan: a case of central nervous system graft-versus-host disease.
Butera S; Tavarozzi R; Brunello L; Rivela P; Sofia A; Viero L; Salvio M; Ladetto M; Zallio F
J Basic Clin Physiol Pharmacol; 2023 Nov; 34(6):805-809. PubMed ID: 37843253
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.
Tsubokura Y; Satake A; Hotta M; Yoshimura H; Fujita S; Azuma Y; Nakanishi T; Nakaya A; Ito T; Ishii K; Nomura S
Int J Hematol; 2016 Dec; 104(6):744-748. PubMed ID: 27573760
[TBL] [Abstract][Full Text] [Related]
16. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
17. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
Fowler DH; Gress RE
Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
19. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.
Inoue Y; Endo S; Matsuno N; Kikukawa Y; Shichijo T; Koga K; Takaki A; Iwanaga K; Nishimura N; Fuji S; Fukuda T; Nosaka K; Matsuoka M
Bone Marrow Transplant; 2019 Feb; 54(2):338-342. PubMed ID: 30116017
[No Abstract] [Full Text] [Related]
20. Acute Pulmonary Graft-Versus-Host Disease in a Patient with Adult T-cell Leukemia-Lymphoma Diagnosed by a Cryobiopsy.
Kobe H; Arita M; Maeda T; Nagata O; Niwa T; Tokioka F; Ishida T
Intern Med; 2021 Jul; 60(14):2269-2273. PubMed ID: 33583892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]